Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...
Pathogen-fighting immune cells called tissue-resident memory CD8 T cells (TRM cells) go through a surprising transformation -- and relocation -- as they fight infections in the small intestine.
These receptors allow T cells to sense and respond to diverse types of infection. A healthy immune system is tolerant to self-antigens while maintaining responsiveness to foreign threats.
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...
A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor (CAR) T-cell therapy ...
A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...
Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...
Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center identified a cocktail of three different drugs that can be used to generate more robust ...
A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...
and CD8-positive suppressor T cells, which restrain certain types of immune response. Interferon-α (IFN-α) is linked to type 1 diabetes (T1D), but how IFN-α impacts auto-antigen presentation is ...